The effects of VEGF/VEGFR interference on cell survival and angiogenesis in AML. Preclinical and clinical studies
PhD ceremony: Ms. A.C. Weidenaar, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertaion: The effects of VEGF/VEGFR interference on cell survival and angiogenesis in AML. Preclinical and clinical studies
Promotor(s): prof. E.S.J.M. de Bont, prof. W.A. Kamps
Faculty: Medical Sciences
Acute Myeloid Leukemia (AML) is a hematological disorder that originates from bone marrow cells. Although most AML patients do respond to chemotherapy treatment, over 40% of them experience a relapse. AML is thought to be initiated and maintained by a subset of self-renewing Leukemic Stem Cells (LSC). To improve outcome, new therapeutic strategies are warranted. Vascular Endothelial Growth Factor (VEGF) is an important growth factor. In (pediatric) AML, VEGF levels are elevated and adversely associated with prognosis. Co-expression of VEGFA and its VEGF-receptors has been reported on AML cells, where VEGF/VEGFR-signaling has proliferative effects. Moreover, increased VEGFA levels are associated with a higher micro vessel density in the bone marrow of newly diagnosed AML patients.
In this thesis we investigated the potential implications of VEGF/VEGFR interference in targeting AML. We first studied the effect of PTK787/ZK 222584 (PTK/ZK), a VEGFR-inhibitor. In leukemic cell cultures (in vitro) we found that PTK/ZK reduced the number of pediatric AML-cells and LSCs. Therefore, PTK/ZK is a potentially effective approach in eradicating pediatric AML-cells and LSCs. In addition, we studied the angiogenesis in bone marrow biopsies of AML patients at diagnosis, and distinguished three morphological phenotypes. AML derived VEGF protein levels were higher in one of the phenotypes. Interestingly, the vessel morphology patterns were related to treatment outcome. These results suggest that vasculature patterns might be a useful tool to predict AML outcome. In conclusion, these studies elucidate the role of VEGFA/VEGFR signaling in AML and provide directions for future treatment strategies.
Last modified: | 13 March 2020 12.58 a.m. |
More news
-
06 June 2025
India-Netherlands Hydrogen Valley Fellowship Programme announced
To coincide with World Environment Day, 5 June 2025, the Indian Department of Science and Technology and the University of Groningen yesterday announced a Hydrogen Valley Fellowship Programme Partnership, allowing talented Indian scholars working on...
-
28 May 2025
Gaan avondmensen cognitief sneller achteruit dan ochtendmensen?
Wie ’s avonds opleeft en laat naar bed gaat, heeft een grotere kans op cognitieve achteruitgang dan een ochtendmens, blijkt uit UMCG-onderzoek.
-
27 May 2025
An adventure in the brain
In the exhibition Brainstorm in the University Mueseum, Iris Sommer and two other brain researchers from Groningen explain the gut-brain connection, how it was discovered that the brain does what it does, and how games motivate you to perform...